We Attended the INTA 2025 Policy Dialogue Panel
“INTA 2025 Policy Dialogue: Intellectual Property Rights and the Protection of Public Health: From Counterfeit/Falsified Medicines to Data Exclusivity” panel was held on 24 November 2025, hosted by the International Trademark Association (INTA) and the Association of Research-Based Pharmaceutical Companies (AİFD).
The opening remarks were delivered by Uğur Aktekin, our partner and a member of INTA’s Famous and Well-Known Marks Committee. The session “Combating Counterfeit/Falsified Medicines” was moderated by our managing associate Direnç Bada and the session “Data Exclusivity and Broader IP Protection for Innovative Medicine” was moderated by our managing associate Dicle Doğan. In the latter session, our partner Özge Atılgan Karakulak participated as a panelist.
During the panel, customs authorities and legal experts discussed the fight against counterfeit/falsified products in the pharmaceutical sector, as well as the significance of data exclusivity for innovative medicines. The event highlighted the critical role of intellectual property rights in public health and in fostering innovation within the sector.
